Alisertib, TAK-228 Combo Shows Promise for Treating Triple-Negative Breast Cancer

Alisertib, TAK-228 Combo Shows Promise for Treating Triple-Negative Breast Cancer
New data presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting, in Philadelphia, demonstrated that using alisertib along with TAK-228, two of Takeda‘s investigational therapies, was more effective in patients with triple-negative breast cancer and solid tumors than either treatment individually. The data come from two different studies conducted at the University of Colorado Cancer Center. The

Knowledge is power when living with breast cancer.

Get access to the web’s leading Breast Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. ZomoOnelo says:

    The general condition of any person formed from the set conditions, among which the most important. Kinds well-being presented difficult system, on which not only common mood depend, but also ability to work of the organism.

    No chance unravel and explore state of health, types well-being, and additionally other components of the healthy strong organism, if thoroughly not go into the next concept. Thus, the health of a person, to date, is called standard and stable psychosomatic state of the individual.
    endometrial biopsy procedure

Leave a Comment

Your email address will not be published. Required fields are marked *